{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:11:47Z","timestamp":1790223107848,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002924","name":"TGF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CNS"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01AI106026"],"award-info":[{"award-number":["#R01AI106026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["# RG-1607-25,366"],"award-info":[{"award-number":["# RG-1607-25,366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"NMSS","doi-asserted-by":"crossref","award":["# FG-1608-25,579"],"award-info":[{"award-number":["# FG-1608-25,579"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#R01AI106026"],"award-info":[{"award-number":["#R01AI106026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["# RG-1607-25366"],"award-info":[{"award-number":["# RG-1607-25366"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"NMSS","doi-asserted-by":"crossref","award":["# FG-1608-25579"],"award-info":[{"award-number":["# FG-1608-25579"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jaut.2020.102505","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T08:47:50Z","timestamp":1593074870000},"page":"102505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Primaquine elicits Foxp3+ regulatory T cells with a superior ability to limit CNS autoimmune inflammation"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7627-4137","authenticated-orcid":false,"given":"Rodolfo","family":"Thome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Lotfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Watanabe Lumi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogoljub","family":"Ciric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolmohamad","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102505_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2020.102505_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2013.06.008","article-title":"Using EAE to better understand principles of immune function and autoimmune pathology","volume":"45","author":"Rangachari","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102505_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jaut.2020.102505_bib5","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/ncomms4770","article-title":"IL-27 and IL-12 oppose pro-inflammatory IL-23 in CD4+ T cells by inducing Blimp1","volume":"5","author":"Heinemann","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2020.102505_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.immuni.2015.08.010","article-title":"The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity","volume":"43","author":"Croxford","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102505_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ni.2027","article-title":"RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation","volume":"12","author":"Codarri","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib9","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.4049\/jimmunol.1403243","article-title":"Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-beta therapy","volume":"194","author":"Rasouli","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2017.12.017","article-title":"Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions","volume":"317","author":"Imitola","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2020.102505_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2020.102505_bib13","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib15","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib16","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006440","article-title":"Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria","volume":"12","author":"Watson","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.jaut.2020.102505_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","article-title":"UK malaria treatment guidelines 2016","volume":"72","author":"Lalloo","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.jaut.2020.102505_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12936-018-2555-3","article-title":"Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines","volume":"17","author":"Berman","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.jaut.2020.102505_bib23","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-019-11239-0","article-title":"Antimalarial activity of primaquine operates via a two-step biochemical relay","volume":"10","author":"Camarda","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2020.102505_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.dmpk.2018.08.004","article-title":"Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation","volume":"33","author":"Saito","year":"2018","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.jaut.2020.102505_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2478\/acph-2018-0021","article-title":"Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells","volume":"68","author":"Mabeta","year":"2018","journal-title":"Acta Pharm."},{"key":"10.1016\/j.jaut.2020.102505_bib26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/cns.12357","article-title":"Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity","volume":"20","author":"Zanucoli","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jaut.2020.102505_bib27","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/eji.201546212","article-title":"Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis","volume":"46","author":"Mari","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib28","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","article-title":"Ido activates regulatory T cells and blocks their conversion into Th17-like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib29","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1126\/science.1073514","article-title":"Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase","volume":"297","author":"Munn","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2020.102505_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2012.09.023","article-title":"Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor","volume":"38","author":"Zaiss","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102505_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.1993","article-title":"Fate mapping of IL-17-producing T cells in inflammatory responses","volume":"12","author":"Hirota","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib32","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1073\/pnas.1114153109","article-title":"CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells","volume":"109","author":"Poppensieker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2020.102505_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2020.102505_bib34","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2020.102505_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nn.4528","article-title":"Regulatory T cells promote myelin regeneration in the central nervous system","volume":"20","author":"Dombrowski","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2020.102505_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib38","doi-asserted-by":"crossref","first-page":"20768","DOI":"10.1073\/pnas.1009201107","article-title":"An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis","volume":"107","author":"Quintana","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2020.102505_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib40","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/WNL.0b013e3182a2ce0e","article-title":"T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients","volume":"81","author":"Balint","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2020.102505_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2020.102505_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nm.3485","article-title":"FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS","volume":"20","author":"Liu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020271","article-title":"Dimethyl fumarate therapy significantly improves the responsiveness of T cells in multiple sclerosis patients for immunoregulation by regulatory T cells","volume":"18","author":"Schloder","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2020.102505_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2017.06.006","article-title":"Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10 years in responder multiple sclerosis patients","volume":"181","author":"Spadaro","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxx049","article-title":"Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation","volume":"29","author":"Someya","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2020.102505_bib48","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1038\/emm.2017.313","article-title":"Transcriptional regulation and development of regulatory T cells","volume":"50","author":"Lee","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib49","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1073\/pnas.1312717110","article-title":"Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation","volume":"111","author":"Morikawa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.jaut.2020.102505_bib50","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1084\/jem.20190550","article-title":"TGF-beta signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity","volume":"216","author":"Sun","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2020.102505_bib51","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.celrep.2019.01.070","article-title":"Blimp1 prevents methylation of Foxp3 and loss of regulatory T cell identity at sites of inflammation","volume":"26","author":"Garg","year":"2019","journal-title":"Cell Rep."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112030127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112030127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:26:00Z","timestamp":1760257560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112030127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S089684112030127X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102505","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primaquine elicits Foxp3+ regulatory T cells with a superior ability to limit CNS autoimmune inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102505"}}